PL2996693T3 - Zastosowanie tiazolopirymidynonu do leczenia nieswoistego zapalenia jelit - Google Patents

Zastosowanie tiazolopirymidynonu do leczenia nieswoistego zapalenia jelit

Info

Publication number
PL2996693T3
PL2996693T3 PL14728622T PL14728622T PL2996693T3 PL 2996693 T3 PL2996693 T3 PL 2996693T3 PL 14728622 T PL14728622 T PL 14728622T PL 14728622 T PL14728622 T PL 14728622T PL 2996693 T3 PL2996693 T3 PL 2996693T3
Authority
PL
Poland
Prior art keywords
thiazolo
pyrimidinone
treatment
inflammatory bowel
bowel disease
Prior art date
Application number
PL14728622T
Other languages
English (en)
Polish (pl)
Inventor
Chaitanya Dutt
Vijay Chauthaiwale
Ram Gupta
Shitalkumar ZAMBAD
Shailesh Deshpande
Jignesh Kotecha
Ramesh Gupta
Sanjay Srivastava
Laxmikant Chhipa
Jaya Abraham
Original Assignee
Torrent Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torrent Pharmaceuticals Ltd filed Critical Torrent Pharmaceuticals Ltd
Publication of PL2996693T3 publication Critical patent/PL2996693T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
PL14728622T 2013-05-14 2014-05-12 Zastosowanie tiazolopirymidynonu do leczenia nieswoistego zapalenia jelit PL2996693T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN1718MU2013 2013-05-14
IN2309MU2013 2013-07-09
EP14728622.3A EP2996693B1 (en) 2013-05-14 2014-05-12 Use of a thiazolo pyrimidinone for the treatment of inflammatory bowel disease
PCT/IB2014/000707 WO2014184631A1 (en) 2013-05-14 2014-05-12 Use of a thiazolo pyrimidinone for the treatment of inflammatory bowel disease

Publications (1)

Publication Number Publication Date
PL2996693T3 true PL2996693T3 (pl) 2019-05-31

Family

ID=50896342

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14728622T PL2996693T3 (pl) 2013-05-14 2014-05-12 Zastosowanie tiazolopirymidynonu do leczenia nieswoistego zapalenia jelit

Country Status (28)

Country Link
US (2) US9610247B2 (OSRAM)
EP (1) EP2996693B1 (OSRAM)
JP (1) JP6407974B2 (OSRAM)
KR (1) KR102239649B1 (OSRAM)
CN (1) CN105209043B (OSRAM)
AU (1) AU2014266968B2 (OSRAM)
BR (1) BR112015028581B1 (OSRAM)
CA (1) CA2912011C (OSRAM)
CY (1) CY1121280T1 (OSRAM)
DK (1) DK2996693T3 (OSRAM)
EA (1) EA030590B1 (OSRAM)
ES (1) ES2712705T3 (OSRAM)
HR (1) HRP20190315T1 (OSRAM)
HU (1) HUE042691T2 (OSRAM)
IL (1) IL242490B (OSRAM)
LT (1) LT2996693T (OSRAM)
MX (1) MX358198B (OSRAM)
MY (1) MY179215A (OSRAM)
PH (1) PH12015502560B1 (OSRAM)
PL (1) PL2996693T3 (OSRAM)
PT (1) PT2996693T (OSRAM)
RS (1) RS58423B1 (OSRAM)
SG (1) SG11201509275PA (OSRAM)
SI (1) SI2996693T1 (OSRAM)
SM (1) SMT201900111T1 (OSRAM)
TW (1) TWI661828B (OSRAM)
UA (1) UA117244C2 (OSRAM)
WO (1) WO2014184631A1 (OSRAM)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI781922B (zh) * 2016-03-14 2022-11-01 日商參天製藥股份有限公司 由葡甲胺或其鹽構成之防腐劑

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009002533A1 (en) * 2007-06-27 2008-12-31 The Brigham And Women's Hospital, Inc. Inflammatory bowel disease therapies
TWI500623B (zh) * 2009-10-13 2015-09-21 Torrent Pharmaceuticals Ltd 新穎稠合噻唑及噁唑嘧啶酮
US8541430B2 (en) * 2009-11-27 2013-09-24 Torrent Pharmaceuticals Limited Fused thiazolo and oxazolo pyrimidinones

Also Published As

Publication number Publication date
CN105209043B (zh) 2019-07-02
HRP20190315T1 (hr) 2019-04-05
CA2912011A1 (en) 2014-11-20
SG11201509275PA (en) 2015-12-30
AU2014266968A1 (en) 2015-12-03
US20160120801A1 (en) 2016-05-05
SI2996693T1 (sl) 2019-04-30
ES2712705T3 (es) 2019-05-14
PH12015502560A1 (en) 2016-02-22
EP2996693B1 (en) 2018-12-12
IL242490B (en) 2018-11-29
US20170157129A1 (en) 2017-06-08
EA030590B1 (ru) 2018-08-31
AU2014266968B2 (en) 2019-09-19
EA201592159A1 (ru) 2016-04-29
US10471005B2 (en) 2019-11-12
CN105209043A (zh) 2015-12-30
US9610247B2 (en) 2017-04-04
UA117244C2 (uk) 2018-07-10
TW201513866A (zh) 2015-04-16
BR112015028581B1 (pt) 2022-05-03
KR102239649B1 (ko) 2021-04-12
KR20160008571A (ko) 2016-01-22
SMT201900111T1 (it) 2019-02-28
TWI661828B (zh) 2019-06-11
MY179215A (en) 2020-11-02
BR112015028581A2 (pt) 2017-07-25
MX2015015682A (es) 2016-07-20
PH12015502560B1 (en) 2016-02-22
PT2996693T (pt) 2019-02-27
HUE042691T2 (hu) 2019-07-29
DK2996693T3 (en) 2019-03-18
NZ714098A (en) 2020-12-18
JP6407974B2 (ja) 2018-10-17
LT2996693T (lt) 2019-03-12
CY1121280T1 (el) 2020-05-29
EP2996693A1 (en) 2016-03-23
WO2014184631A1 (en) 2014-11-20
MX358198B (es) 2018-08-08
CA2912011C (en) 2021-10-26
JP2016518440A (ja) 2016-06-23
RS58423B1 (sr) 2019-04-30

Similar Documents

Publication Publication Date Title
SG11202012656WA (en) Heterocyclic compounds useful in the treatment of disease
IL243976A0 (en) kdm1a inhibitors for disease treatment
AU355472S (en) Body camera
SG11201600571RA (en) Imaging neurological disease
ZA201507718B (en) The local treatment of inflammatory ophthalmic diseases
SG11201505692QA (en) Reducing the risk of autoimmune disease
PT3021873T (pt) Métodos para o tratamento da doença inflamatória da articulação
PT2956136T (pt) D-fagomina para a prevenção do aparecimento de doenças autoimunes
IL242490B (en) Use of thiazolopyrimidinone to treat inflammatory bowel disease
PL3065678T3 (pl) Pessarium terapeutyczne
GB201303796D0 (en) Condom
PL2870968T3 (pl) Leczenie klinoptilolitem zapalnych chorób jelit
TH1501006822A (th) การใช้ไทอะโซโล ไพริมิดิโนนสำหรับการรักษาโรคลำไส้อักเสบ
GB201304194D0 (en) Use of cladribine for treating autoimmune inflammatory disease
GB201321628D0 (en) Treatment of disease
IL244505A0 (en) Tissue with a pattern
GB201318303D0 (en) Bedpan
SG11201506509TA (en) Use of pidotimod to treat inflammatory bowel disease
SG2013009600A (en) A tiltable commode
GB201300065D0 (en) The cleaning of body parts